Page last updated: 2024-10-16

carbon monoxide and 2019 Novel Coronavirus Disease

carbon monoxide has been researched along with 2019 Novel Coronavirus Disease in 36 studies

Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.

Research Excerpts

ExcerptRelevanceReference
"The purpose of this study was to assess exercise capacity, lung and physical function in COVID-19 survivors, and the association of lesion-level characteristics assessed by chest computed tomography, probable sarcopenia, and percentage of diffusing capacity of the lung for carbon monoxide with clinical and functional variables."4.31Lung and physical function in post COVID-19 and clinical and functional associations: a cross-sectional study in Brazil. ( Almeida, KO; Alves, IGN; Gomes-Neto, M; Jezler, SFO; Moura, DM; Nascimento, WLCD, 2023)
" For the method of the attempt, hanging and carbon monoxide/gas poisoning decreased, whereas jumping from a height and drowning increased."4.12Changes in self-harm attempts after the COVID-19 pandemic based on pre-hospital medical records. ( Gyu Kwak, S; Kim, NM; Seo, YW, 2022)
"In some patients, coronavirus disease 2019 (COVID-19) is accompanied by loss of smell and taste, and this has been reportedly associated with exposure to air pollutants."1.72Effects of Air Pollution on Chemosensory Dysfunction in COVID-19 Patients. ( Choi, YS; Jeong, BS; Kim, YD; Lee, YK, 2022)
"Many coronavirus disease 2019 (Covid-19) survivors show symptoms months after acute illness."1.62Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19. ( Amico, CS; Avanzi, GC; Balbo, PE; Baricich, A; Barini, M; Battaglia, M; Bellan, M; Bor, S; Cantaluppi, V; Cappellano, G; Carriero, A; Ceruti, F; Chiocchetti, A; Clivati, E; Cuneo, D; Gambaro, E; Gattoni, E; Giordano, M; Gramaglia, C; Loro, A; Manfredi, M; Morosini, U; Murano, F; Paracchini, E; Patrucco, F; Patti, G; Pinato, DJ; Pirisi, M; Raineri, D; Rolla, R; Sainaghi, PP; Tricca, S; Zeppegno, P, 2021)
"Patients recovering from coronavirus disease 2019 (COVID-19) may not return to a pre-COVID functional status and baseline levels of healthcare needs after discharge from acute care hospitals."1.62Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients. ( Ambrosino, P; Cazzola, M; Fuschillo, S; Maniscalco, M; Martucci, M; Matera, MG; Papa, A, 2021)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's36 (100.00)2.80

Authors

AuthorsStudies
Ali, G1
Abbas, S1
Qamer, FM1
Irteza, SM1
Bellan, M1
Baricich, A1
Patrucco, F1
Zeppegno, P1
Gramaglia, C1
Balbo, PE1
Carriero, A1
Amico, CS1
Avanzi, GC1
Barini, M1
Battaglia, M1
Bor, S1
Cantaluppi, V1
Cappellano, G1
Ceruti, F1
Chiocchetti, A1
Clivati, E1
Giordano, M1
Cuneo, D1
Gambaro, E1
Gattoni, E1
Loro, A1
Manfredi, M1
Morosini, U1
Murano, F1
Paracchini, E1
Patti, G1
Pinato, DJ1
Raineri, D1
Rolla, R1
Sainaghi, PP1
Tricca, S1
Pirisi, M1
Lopez-Coto, I1
Ren, X1
Karion, A1
McKain, K1
Sweeney, C1
Dickerson, RR1
McDonald, BC1
Ahn, DY1
Salawitch, RJ1
He, H1
Shepson, PB1
Whetstone, JR1
Luk, TT1
Cheung, YTD1
Chan, HC1
Fok, PW1
Ho, KS1
Sze, CD1
Lam, TH1
Wang, MP1
Wang, K1
Wang, X2
Cheng, S1
Cheng, L1
Wang, R1
Matheson, AM1
McIntosh, MJ1
Kooner, HK1
Lee, J1
Desaigoudar, V1
Bier, E1
Driehuys, B1
Svenningsen, S1
Santyr, GE1
Kirby, M1
Albert, MS1
Shepelytskyi, Y1
Grynko, V1
Ouriadov, A1
Abdelrazek, M1
Dhaliwal, I1
Nicholson, JM1
Parraga, G1
Ikonomidis, I1
Katogiannis, K1
Kourea, K1
Gavriella, K1
Tsilivarakis, D1
Lambadiari, V1
Kouretas, D1
Biondi-Zoccai, G1
Gülhan, PY1
Arbak, PM1
Annakkaya, AN1
Balbay, EG1
Balbay, ÖA1
Konkol, SB1
Ramani, C1
Martin, DN1
Harnish-Cruz, CK1
Mietla, KM1
Sessums, RF1
Widere, JC1
Kadl, A1
Hernandez Carballo, I1
Bakola, M1
Stuckler, D1
Kim, NM1
Seo, YW1
Gyu Kwak, S1
Choi, YS1
Jeong, BS1
Lee, YK1
Kim, YD1
Liu, S1
Yang, X1
Duan, F1
Zhao, W1
de Oliveira, TCP1
Gardel, DG1
Ghetti, ATA1
Lopes, AJ1
Muschol, J1
Heinrich, M1
Heiss, C1
Hernandez, AM1
Knapp, G1
Repp, H1
Schneider, H1
Thormann, U1
Uhlar, J1
Unzeitig, K1
Gissel, C1
Núñez-Fernández, M1
Ramos-Hernández, C1
García-Río, F1
Pérez-González, A1
Tilve-Gómez, A1
Rodríguez-Fernández, P1
Nodar-Germiñas, A1
Fernández-García, A1
Ruano-Raviña, A1
Fernández-Villar, A1
Nascimento, WLCD1
Moura, DM1
Almeida, KO1
Gomes-Neto, M1
Jezler, SFO1
Alves, IGN1
Rahmati, M1
Udeh, R1
Yon, DK1
Lee, SW1
Dolja-Gore, X1
McEVoy, M1
Kenna, T1
Jacob, L1
López Sánchez, GF1
Koyanagi, A1
Shin, JI1
Smith, L1
Kerget, B1
Özkan, HB1
Alper, F1
Akgün, M1
Alaniz, AJ1
Vergara, PM1
Carvajal, JG1
Carvajal, MA1
van Willigen, HDG1
Wynberg, E1
Verveen, A1
Dijkstra, M1
Verkaik, BJ1
Figaroa, OJA1
de Jong, MC1
van der Veen, ALIP1
Makowska, A1
Koedoot, N1
Nieuwkerk, PT1
Boyd, A1
Prins, M1
de Jong, MD1
de Bree, GJ1
van den Aardweg, JG1
Dantas, G1
Siciliano, B1
França, BB1
da Silva, CM1
Arbilla, G1
Kanniah, KD1
Kamarul Zaman, NAF1
Kaskaoutis, DG1
Latif, MT1
Li, H2
Xu, XL1
Dai, DW1
Huang, ZY1
Ma, Z1
Guan, YJ1
Hoang, T2
Tran, TTA2
Nusair, S1
Meo, SA3
Abukhalaf, AA3
Alomar, AA2
Alessa, OM3
Chapman, DG1
Badal, T1
King, GG1
Thamrin, C1
Brimblecombe, P1
Lai, Y1
Nguyen, TQ1
Sami, W1
Klonoff, DC1
Qin, W1
Chen, S1
Zhang, Y1
Dong, F1
Zhang, Z1
Hu, B1
Zhu, Z1
Li, F1
Wang, Y1
Zhen, K1
Wang, J1
Wan, Y1
Elalamy, I1
Li, C1
Zhai, Z1
Wang, C1
E, E1
R, F1
Öi, E1
Im, L1
M, L1
S, R1
E, W1
C, J1
M, H1
A, M1
Fuschillo, S2
Ambrosino, P2
Motta, A1
Maniscalco, M2
Martucci, M1
Papa, A1
Matera, MG1
Cazzola, M1
Almutairi, FJ1
Al-Khlaiwi, T1
Meo, AS1

Clinical Trials (4)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Chat-based Instant Messaging Support for Preventing Smoking Relapse in the Context of COVID-19 Outbreak: a Pilot Randomised Clinical Trial[NCT04409496]108 participants (Actual)Interventional2020-06-02Completed
Effectiveness of Mobile Chat Messaging for Preventing Relapse in Smokers Who Have Recently Quit Smoking: a Randomised Controlled Trial[NCT05370352]586 participants (Anticipated)Interventional2023-03-14Recruiting
Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI and CT For Rapid Evaluations and NExt-wave Healthcare Planning[NCT04584671]100 participants (Anticipated)Observational2021-01-01Active, not recruiting
Uppföljning av Patienter Som intensivvårdats för COVID-19[NCT04474249]300 participants (Anticipated)Observational2020-06-25Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for carbon monoxide and 2019 Novel Coronavirus Disease

ArticleYear
The impact of air pollution on COVID-19 incidence, severity, and mortality: A systematic review of studies in Europe and North America.
    Environmental research, 2022, Volume: 215, Issue:Pt 1

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; COVID-19; Environmental Exposure; Humans; Incidence;

2022
A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    Journal of medical virology, 2023, Volume: 95, Issue:6

    Topics: Anxiety; Carbon Monoxide; COVID-19; Disease Progression; Female; Humans; Male; Post-Acute COVID-19 S

2023
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge.
    Respiratory medicine, 2021, Volume: 182

    Topics: Carbon Monoxide; COVID-19; Critical Illness; Humans; Lung; Patient Discharge; Pulmonary Diffusing Ca

2021

Trials

2 trials available for carbon monoxide and 2019 Novel Coronavirus Disease

ArticleYear
Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 01-05, Volume: 25, Issue:2

    Topics: Adult; Carbon Monoxide; COVID-19; Humans; Pandemics; Pilot Projects; Smoking; Text Messaging

2023
Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 01-05, Volume: 25, Issue:2

    Topics: Adult; Carbon Monoxide; COVID-19; Humans; Pandemics; Pilot Projects; Smoking; Text Messaging

2023
Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 01-05, Volume: 25, Issue:2

    Topics: Adult; Carbon Monoxide; COVID-19; Humans; Pandemics; Pilot Projects; Smoking; Text Messaging

2023
Mobile Chat Messaging for Preventing Smoking Relapse Amid the COVID-19 Pandemic: A Pilot Randomized Controlled Trial.
    Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2023, 01-05, Volume: 25, Issue:2

    Topics: Adult; Carbon Monoxide; COVID-19; Humans; Pandemics; Pilot Projects; Smoking; Text Messaging

2023
Economic and Environmental Impact of Digital Health App Video Consultations in Follow-up Care for Patients in Orthopedic and Trauma Surgery in Germany: Randomized Controlled Trial.
    Journal of medical Internet research, 2022, 11-24, Volume: 24, Issue:11

    Topics: Aftercare; Carbon Monoxide; COVID-19; Environment; Germany; Greenhouse Gases; Humans; Mobile Applica

2022

Other Studies

31 other studies available for carbon monoxide and 2019 Novel Coronavirus Disease

ArticleYear
Environmental spatial heterogeneity of the impacts of COVID-19 on the top-20 metropolitan cities of Asia-Pacific.
    Scientific reports, 2021, 10-13, Volume: 11, Issue:1

    Topics: Aerosols; Air Pollutants; Air Pollution; Asia, Eastern; Asia, Southeastern; Carbon Monoxide; Cities;

2021
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19.
    Scientific reports, 2021, 11-22, Volume: 11, Issue:1

    Topics: Aged; Carbon Monoxide; COVID-19; Female; Hospitalization; Humans; Italy; Logistic Models; Male; Ment

2021
Carbon Monoxide Emissions from the Washington, DC, and Baltimore Metropolitan Area: Recent Trend and COVID-19 Anomaly.
    Environmental science & technology, 2022, 02-15, Volume: 56, Issue:4

    Topics: Air Pollutants; Baltimore; Carbon Monoxide; COVID-19; District of Columbia; Environmental Monitoring

2022
National emissions inventory and future trends in greenhouse gases and other air pollutants from civil airports in China.
    Environmental science and pollution research international, 2022, Volume: 29, Issue:54

    Topics: Acetaldehyde; Acetone; Air Pollutants; Air Pollution; Airports; Carbon Dioxide; Carbon Monoxide; Chi

2022
Persistent
    Radiology, 2022, Volume: 305, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbon Monoxide; COVID-19; Dyspnea; Female; Humans; Lung

2022
The effect of smoking on exhaled carbon monoxide and arterial elasticity during prolonged surgical mask use in the COVID-19 era.
    European journal of preventive cardiology, 2022, 11-15, Volume: 29, Issue:16

    Topics: Breath Tests; Carbon Monoxide; COVID-19; Elasticity; Humans; Smoking; Tobacco Smoking

2022
An assessment of post-COVID-19 infection pulmonary functions in healthcare professionals.
    American journal of infection control, 2022, Volume: 50, Issue:10

    Topics: Adult; Carbon Monoxide; COVID-19; Delivery of Health Care; Dyspnea; Female; Humans; Lung; Male; Midd

2022
Differences in lung function between major race/ethnicity groups following hospitalization with COVID-19.
    Respiratory medicine, 2022, Volume: 201

    Topics: Carbon Monoxide; COVID-19; Ethnicity; Hospitalization; Humans; Lung

2022
Changes in self-harm attempts after the COVID-19 pandemic based on pre-hospital medical records.
    Medicine, 2022, Sep-16, Volume: 101, Issue:37

    Topics: Carbon Monoxide; COVID-19; Female; Gas Poisoning; Hospitals; Humans; Medical Records; Pandemics; Ret

2022
Effects of Air Pollution on Chemosensory Dysfunction in COVID-19 Patients.
    Journal of Korean medical science, 2022, Oct-10, Volume: 37, Issue:39

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; China; COVID-19; Humans; Nitrogen Dioxide; Ozone; Pa

2022
Changes in Air Quality and Drivers for the Heavy PM
    International journal of environmental research and public health, 2022, 10-08, Volume: 19, Issue:19

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; China; Communicable Disease Control; COVID-19; Envir

2022
The Glittre-ADL test in non-hospitalized patients with post-COVID-19 syndrome and its relationship with muscle strength and lung function.
    Clinical biomechanics (Bristol, Avon), 2022, Volume: 100

    Topics: Activities of Daily Living; Carbon Monoxide; COVID-19; Cross-Sectional Studies; Female; Hand Strengt

2022
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value.
    Respiratory research, 2023, Feb-13, Volume: 24, Issue:1

    Topics: Carbon Monoxide; COVID-19; Female; Humans; Lung; Male; Middle Aged; Nitric Oxide; Prospective Studie

2023
Lung and physical function in post COVID-19 and clinical and functional associations: a cross-sectional study in Brazil.
    Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:4

    Topics: Brazil; Carbon Monoxide; COVID-19; Cross-Sectional Studies; Humans; Lung; Sarcopenia; SARS-CoV-2

2023
Evaluation of the value of exhaled carbon monoxide in the differentiation of viral and bacterial pneumonia.
    Biomarkers in medicine, 2023, Volume: 17, Issue:7

    Topics: Breath Tests; Carbon Monoxide; COVID-19; Exhalation; Heme Oxygenase (Decyclizing); Humans; Pneumonia

2023
Unraveling the socio-environmental drivers during the early COVID-19 pandemic in China.
    Environmental science and pollution research international, 2023, Volume: 30, Issue:30

    Topics: Air Pollutants; Air Pollution; Bayes Theorem; Carbon Monoxide; China; COVID-19; Environmental Monito

2023
One-fourth of COVID-19 patients have an impaired pulmonary function after 12 months of disease onset.
    PloS one, 2023, Volume: 18, Issue:9

    Topics: Carbon Monoxide; COVID-19; Humans; Prospective Studies; Quality of Life; SARS-CoV-2

2023
The impact of COVID-19 partial lockdown on the air quality of the city of Rio de Janeiro, Brazil.
    The Science of the total environment, 2020, Aug-10, Volume: 729

    Topics: Air Pollutants; Air Pollution; Betacoronavirus; Brazil; Carbon Monoxide; Cities; Coronavirus Infecti

2020
COVID-19's impact on the atmospheric environment in the Southeast Asia region.
    The Science of the total environment, 2020, Sep-20, Volume: 736

    Topics: Air Pollution; Asia, Southeastern; Betacoronavirus; Carbon Monoxide; Coronavirus Infections; COVID-1

2020
Air pollution and temperature are associated with increased COVID-19 incidence: A time series study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97

    Topics: Air Pollution; Betacoronavirus; Carbon Monoxide; China; Cities; Coronavirus Infections; COVID-19; Hu

2020
Ambient air pollution, meteorology, and COVID-19 infection in Korea.
    Journal of medical virology, 2021, Volume: 93, Issue:2

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cities; COVID-19; Humans; Meteorology; Nitrogen Diox

2021
Abnormal carbon monoxide diffusion capacity in COVID-19 patients at time of hospital discharge.
    The European respiratory journal, 2020, Volume: 56, Issue:1

    Topics: Betacoronavirus; Carbon Monoxide; Coronavirus Infections; COVID-19; Humans; Lung; Pandemics; Patient

2020
Wildfire and COVID-19 pandemic: effect of environmental pollution PM-2.5 and carbon monoxide on the dynamics of daily cases and deaths due to SARS-COV-2 infection in San-Francisco USA.
    European review for medical and pharmacological sciences, 2020, Volume: 24, Issue:19

    Topics: Atmosphere; Carbon Monoxide; COVID-19; Databases, Factual; Environmental Pollution; Female; Humans;

2020
Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients.
    The European respiratory journal, 2021, Volume: 57, Issue:1

    Topics: Carbon Monoxide; COVID-19; Hospitals; Humans; Patient Discharge; Pulmonary Diffusing Capacity; SARS-

2021
Diurnal and weekly patterns of primary pollutants in Beijing under COVID-19 restrictions.
    Faraday discussions, 2021, 03-01, Volume: 226

    Topics: Air Pollutants; Beijing; Carbon Monoxide; COVID-19; Environmental Monitoring; Humans; Nitrogen Dioxi

2021
Short-term exposure to ambient air pollution in association with COVID-19 of two clusters in South Korea.
    Tropical medicine & international health : TM & IH, 2021, Volume: 26, Issue:4

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; Cities; Cluster Analysis; COVID-19; Humans; Meteorol

2021
Effect of environmental pollutants PM-2.5, carbon monoxide, and ozone on the incidence and mortality of SARS-COV-2 infection in ten wildfire affected counties in California.
    The Science of the total environment, 2021, Feb-25, Volume: 757

    Topics: Air Pollutants; Air Pollution; California; Carbon Monoxide; COVID-19; Environmental Pollutants; Huma

2021
Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up.
    The European respiratory journal, 2021, Volume: 58, Issue:1

    Topics: Carbon Monoxide; China; COVID-19; Follow-Up Studies; Humans; Lung; SARS-CoV-2

2021
COVID-19 and diffusing capacity of the lungs for carbon monoxide: a clinical biomarker in postacute care settings.
    Biomarkers in medicine, 2021, Volume: 15, Issue:8

    Topics: Biomarkers; Carbon Monoxide; COVID-19; Humans; Pulmonary Diffusing Capacity; SARS-CoV-2; Subacute Ca

2021
Preexisting cardiorespiratory comorbidity does not preclude the success of multidisciplinary rehabilitation in post-COVID-19 patients.
    Respiratory medicine, 2021, Volume: 184

    Topics: Carbon Monoxide; Cardiovascular Diseases; Comorbidity; COVID-19; Female; Forced Expiratory Volume; H

2021
Sandstorm and its effect on particulate matter PM 2.5, carbon monoxide, nitrogen dioxide, ozone pollutants and SARS-CoV-2 cases and deaths.
    The Science of the total environment, 2021, Nov-15, Volume: 795

    Topics: Air Pollutants; Air Pollution; Carbon Monoxide; COVID-19; Environmental Pollutants; Humans; Nitric O

2021